Overview
Estenda Solutions provides professional services to design, build, and deploy custom software, data analytics, and AI/ML solutions for digital health, medtech, and life sciences. The company creates digital health tools such as digital therapeutics, clinical decision support systems, and platforms for real-world evidence, using web, mobile, and cloud technologies along with advanced analytics and machine learning to turn data into usable software for healthcare users. What sets Estenda apart is its deep industry focus and regulatory readiness: they have ISO 13485 certification and experience delivering FDA-compliant software, ensuring products meet regulatory requirements. The goal is to help healthcare organizations—from startups to global enterprises, academic groups, and clinical institutions—improve patient outcomes, accelerate research, and drive healthcare innovation by delivering tailored technology that aligns with users’ needs and business objectives.
Work here?Claim your company
Simplify's Take
What believers are saying
- August 2026 content shows active AI thought leadership and fresh market visibility.
- September 2026 pages emphasize implementation support, expanding beyond one-off development contracts.
- The May 2025 NIH R44DC022498 award validates Estenda's research credibility and funding access.
What critics are saying
- Estenda sells project services; revenue stops when budgets or grants end.
- Accenture, Deloitte, and health-system internal teams commoditize custom digital-health build work.
- If 75H70426F80016 or Hub4Smell stalls, Estenda loses a flagship commercialization story.
What makes Estenda Solutions unique
- Estenda pairs ISO13485-certified software delivery with clinical research and validation.
- Its September 2026 services page highlights NIH, Robert Wood Johnson Foundation, and other funders.
- Estenda builds digital therapeutics, telehealth, and AI tools for regulated healthcare workflows.
Help us improve and share your feedback! Did you find this helpful?